You are here

SYNERGY PC CARRY ELECTRONIC COMMUNICATION DEVICE

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: GM57496-01
Agency Tracking Number: 39385
Amount: $99,980.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1997
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
412 HIGH PLAIN ST, #19
Walpole, MA 02010
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 MC ARDLE, BRUCE G
 () -
Business Contact
Phone: (508) 668-7424
Research Institution
N/A
Abstract

DESCRIPTION: (Adapted from the applicant's abstract) Synergy will produce a prototype for the Synergy PC-Carry Electronic Communication Device, a PC- Computer-based speech prosthesis for ambulatory persons with communication and or cognitive deficits. Survey of customers and review of the available prostheses reveal a demand for this product. Research will be conducted at Synergy and at the consultants site over 6 months. The product's major criteria are (1) highly durable, (2)lightweight and easily carried, (3) high quality speech output, (4) quick and easy to use in any position, (5) promotes language development, (6) useful in therapeutic settings, (7) easy to use with variable fine-motor and visual skills, (8) screen visible in multiple lighting settings, (9) usable by people with various types of disability, (10) easy to operate physically, (11) easy to operate cognitively, (12) minimal technical knowledge $ = TOTAL AWARD AMTS & NOT LIMITED TO PORTION OF PROJECT RELATED TO SUBJECT OF SEARCH SUBPROJECT $ = TOTAL AWARD AMOUNT DIVIDED BY NUMBER OF SUBPROJECTS SOURCE: CRISP FORMAT F FY 97 LAST UPDATE 04-07-98 1QUERY 1536 ID SEARCH 06/01/98 PAGE 360 --PROJECT NUMBER......1 R43 GM57669-01 INVESTIGATOR NAME/ADDRESS FY 97 HONEYCUTT, RHONDA J IRG/INTRAMURAL UNIT..ZRG5 PHENOTYPICS CORPORATION AWARD AMOUNT......... $94,763 3099 SCIENCES PARK RD SAN DIEGO, CA 92121 PERFORMING ORGANIZATION: PHENOTYPICS TITLE PCR OF TRNA INTERGENIC SPACERS--EPIDEMIOLOGY/DIAGNOSTICS ABSTRACT: DESCRIPTION: tRNA genes are generally found clustered, head-to-tail in eubacterial, mitochondrial and chloroplast genomes, and in assorted orientations in the nuclear genomes of species in other kingdons. Unlike the tRNA genes, the spacer regions between genes evolve rapidly and vary in length between related species. PCR primers that are derived from tRNA gene consensus sequences can be developed from each major group of pathogenic fungi. When these primers are used for low stringency PCR, a species-specific fingerprint is generated that detects gene rearrangements and length polymorphisms in the spacers. In this six month feasibility project, the investigators will demonstrate that a set of tRNA gene consensus primers can be developed for major groups of fungal pathogens of humans. In later studies, intergenic spacers showing length polymorphisms among related species or sub-species can be cloned and sequenced. Then a single pair of primers can be designed to detect the spacer length polymorphisms, a feature that makes these PCR products diffeent from most conventional PCR. Such primer will find many uses in diagnosis. $ = TOTAL AWARD AMTS & NOT LIMITED TO PORTION OF PROJECT RELATED TO SUBJECT OF SEARCH SUBPROJECT $ = TOTAL AWARD AMOUNT DIVIDED BY NUMBER OF SUBPROJECTS SOURCE: CRISP FORMAT F FY 97 LAST UPDATE 04-07-98 1QUERY 1536 ID SEARCH 06/01/98 PAGE 361 --PROJECT NUMBER......9 R44 GM57758-02 INVESTIGATOR NAME/ADDRESS FY 97 WAGONER, P KAY IRG/INTRAMURAL UNIT..ZRG3 ICAGEN INC AWARD AMOUNT......... $341,401 4222 EMPEROR BLVD SUITE 460 DURHAM NC 27703 PERFORMING ORGANIZATION: ICAGEN, INC. TITLE FUNCTIONAL ASSAYS FOR ION CHANNEL DRUG TARGETS NO ABSTRACT ON FILE $ = TOTAL AWARD AMTS & NOT LIMITED TO PORTION OF PROJECT RELATED TO SUBJECT OF SEARCH SUBPROJECT $ = TOTAL AWARD AMOUNT DIVIDED BY NUMBER OF SUBPROJECTS SOURCE: CRISP FORMAT F FY 97 LAST UPDATE 04-07-98 1QUERY 1536 ID SEARCH 06/01/98 PAGE 362 --PROJECT NUMBER......2 R44 HD31774-02A1 INVESTIGATOR NAME/ADDRESS FY 97 KHALSA, ARJAN S IRG/INTRAMURAL UNIT..ZRG5 INTELLITOOLS, INC AWARD AMOUNT......... $319,959 55 LEVERONI COURT, SUITE 9 NOVATO, CA 94949 PERFORMING ORGANIZATION: INTELLITOOLS,INC. TITLE LANGUAGE ARTS KEYBOARD OVERLAYS FOR DISABLED STUDENTS NO ABSTRACT ON FILE $ = TOTAL AWARD AMTS & NOT LIMITED TO PORTION OF PROJECT RELATED TO SUBJECT OF SEARCH SUBPROJECT $ = TOTAL AWARD AMOUNT DIVIDED BY NUMBER OF SUBPROJECTS SOURCE: CRISP FORMAT F FY 97 LAST UPDATE 04-07-98 1QUERY 1536 ID SEARCH 06/01/98 PAGE 363 --PROJECT NUMBER......2 R44 HD31837-02 INVESTIGATOR NAME/ADDRESS FY 97 NGUYEN, DUONG IRG/INTRAMURAL UNIT..ZRG7 ROSE BIOMEDICAL DEV CORP AWARD AMOUNT......... $407,053 4545 E 9TH AVENUE DENVER, CO 80220 PERFORMING ORGANIZATION: ROSE BIOMEDICAL DEVELOPMENT CORPORATION TITLE DECISION SUPPORT SYSTEM TO IDENTIFY THE AT RISK FETUS ABSTRACT: In Phase I of the "Decision Support System to Identify the At-Risk Fetus" a prototype Intelligent Decision Support System (IDSS) was developed to interpret electronic fetal monitoring (EFM) data. In Phase II, the researchers propose to complete development and test the IDSS in preparation for full clinical trials and commercialization. The research is based on the hypothesis that intrapartum EFM and the resulting FHR and UC data provide information that can assist physicians in more accurately differentiating between healthy and at-risk fetuses. The system uses morphological filters to process signals at different scales, a neural network to better recognize FHR and UC patterns despite EFM noise, and a fuzzy relational structure outcome inferencing. In Phase I evidence was generated supporting the hypothesis when the IDSS with little training on only 50 cases differentiated between healthy and at-risk fetuses as well, and perhaps slightly better than three board certified obstetricians with over 40 years of combined clinical experience. The proposed Phase II improvements to IDSS would increase the system's sensitivity and specificity so as to assist clinicians in more accurately identifying at-risk fetuses, as well as more confidently identifying healthy fetuses so as to avoid unnecessary interventions.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government